Imatinib Unknown Status Phase 1 Trials for Unspecified Adult Solid Tumor, Protocol Specific Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00483366Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors (Closed to Accrual 12/11/2008)